Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus dapagliflozin for treatment of polycystic ovary syndrome
IRCT20240520061850N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin and dapagliflozin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
metformindapagliflozin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20240520061850N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240520061850N1.